Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia
Background:
MicroRNA-34a (miR-34a), as a tumor-suppressive miRNA, has been found to induce cell apoptosis in acute myeloid leukemia (AML). However, the diagnostic and prognostic significance of miR-34a in AML remains largely unknown.
Objective:
We aimed to explore its associations with clinical characteristics and prognosis of AML patients.
Methods:
This study detected serum miR-34a level in 117 diagnosed AML patients and 60 control subjects by using qRT-PCR, and results were compared to clinical features and patient outcome. Since cytogenetically-normal AML (CN-AML) has a good uniformity of cytogenetics and provides a perfect platform for detection of AML biomarkers, we further analyzed miR-34a expression in 56 CN-AML subjects.
Results:
We found that miR-34a was significantly downregulated in AML and CN-AML patients. MiR-34a underexpression was commonly observed in AML patients with intermediate/poor risk cytogenetic, and M5 subtype. ROC analysis demonstrated that serum miR-34a could well identify AML/CN-AML patients from healthy individuals. More importantly, miR-34a expression was found negatively correlated with aggressive clinical variable, and served as an independent prognostic indicator. In addition, AML/CN-AML patients with low miR-34a expression displayed shorter overall and recurrence free survival.
Conclusions:
Altogether, miR-34a might have an application as a diagnostic and prognostic indicator for AML patients.
Insights
MicroRNA-34a (miR-34a) is downregulated in acute myeloid leukemia (AML) and can serve as a diagnostic and prognostic biomarker. Lower miR-34a levels correlate with poorer outcomes in AML patients.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- MicroRNA-34a (miR-34a) is a known tumor suppressor inducing apoptosis in acute myeloid leukemia (AML).
- The diagnostic and prognostic value of miR-34a in AML is not well-established.
- Investigating miR-34a's role can uncover potential biomarkers for AML diagnosis and prognosis.
Purpose of the Study:
- To investigate the association of serum miR-34a levels with clinical characteristics in AML patients.
- To evaluate the diagnostic and prognostic significance of miR-34a in AML.
- To analyze miR-34a expression in cytogenetically-normal AML (CN-AML) for biomarker potential.
Main Methods:
- Serum miR-34a levels were quantified using qRT-PCR in 117 AML patients and 60 controls.
- miR-34a expression was further analyzed in 56 CN-AML subjects.
- Correlations with clinical features, patient outcomes, and diagnostic accuracy (ROC analysis) were assessed.
Main Results:
- miR-34a was significantly downregulated in AML and CN-AML patients compared to controls.
- Underexpression of miR-34a was linked to intermediate/poor risk cytogenetics and the M5 subtype.
- Serum miR-34a demonstrated diagnostic potential and served as an independent prognostic indicator, with lower levels associated with shorter survival.
Conclusions:
- miR-34a exhibits potential as a diagnostic biomarker for distinguishing AML patients from healthy individuals.
- miR-34a serves as a valuable prognostic indicator in AML, correlating with patient survival and disease recurrence.
- The findings suggest miR-34a could be a significant clinical tool for AML management.
Related Concept Videos
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Potential Energy
Standard Electrode Potentials
Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
Differentiation of Common Myeloid Progenitor Cells
The Resting Membrane Potential


